162 related articles for article (PubMed ID: 11967952)
1. Differentiation and stromal-induced growth promotion of murine prostatic tumors.
Salm SN; Takao T; Tsujimura A; Coetzee S; Moscatelli D; Wilson EL
Prostate; 2002 May; 51(3):175-88. PubMed ID: 11967952
[TBL] [Abstract][Full Text] [Related]
2. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
[TBL] [Abstract][Full Text] [Related]
3. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
4. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
6. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
[TBL] [Abstract][Full Text] [Related]
8. Stromal/epithelial interactions of murine prostatic cell lines in vivo: a model for benign prostatic hyperplasia and the effect of doxazosin on tissue size.
Takao T; Tsujimura A; Coetzee S; Salm SN; Lepor H; Shapiro E; Moscatelli D; Wilson EL
Prostate; 2003 Jan; 54(1):17-24. PubMed ID: 12481251
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Dec; 185(3):416-24. PubMed ID: 11056012
[TBL] [Abstract][Full Text] [Related]
10. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells.
Peehl DM; Sellers RG
Exp Cell Res; 1997 May; 232(2):208-15. PubMed ID: 9168795
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phenotype of human prostatic stromal cells by transforming growth factor-betas.
Hisataki T; Itoh N; Suzuki K; Takahashi A; Masumori N; Tohse N; Ohmori Y; Yamada S; Tsukamoto T
Prostate; 2004 Feb; 58(2):174-82. PubMed ID: 14716743
[TBL] [Abstract][Full Text] [Related]
12. A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation.
Daly-Burns B; Alam TN; Mackay A; Clark J; Shepherd CJ; Rizzo S; Tatoud R; O'Hare MJ; Masters JR; Hudson DL
Differentiation; 2007 Jan; 75(1):35-48. PubMed ID: 17244020
[TBL] [Abstract][Full Text] [Related]
13. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.
Danielpour D; Kadomatsu K; Anzano MA; Smith JM; Sporn MB
Cancer Res; 1994 Jul; 54(13):3413-21. PubMed ID: 8012960
[TBL] [Abstract][Full Text] [Related]
16. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones.
Kirschenbaum A; Liu XH; Yao S; Narla G; Friedman SL; Martignetti JA; Levine AC
Carcinogenesis; 2006 Feb; 27(2):216-24. PubMed ID: 16123118
[TBL] [Abstract][Full Text] [Related]
17. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
[TBL] [Abstract][Full Text] [Related]
19. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates.
Lang SH; Stower M; Maitland NJ
Br J Cancer; 2000 Feb; 82(4):990-7. PubMed ID: 10732776
[TBL] [Abstract][Full Text] [Related]
20. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1.
Corallini A; Possati L; Trabanelli C; Giraudo E; Rocchetti R; Talevi S; Caputo A; Bussolino F; Barbanti-Brodano G
Carcinogenesis; 2003 Sep; 24(9):1435-44. PubMed ID: 12844479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
